M-GenSeg: Domain Adaptation For Target Modality Tumor Segmentation With Annotation-Efficient Supervision
원문 초록
Automated medical image segmentation using deep neural networks typically requires substantial supervised training. However, these models fail to generalize well across different imaging modalities. This shortcoming, amplified by the limited availability of expert annotated data, has been hampering the deployment of such methods at a larger scale across modalities. To address these issues, we propose M-GenSeg, a new semi-supervised generative training strategy for cross-modality tumor segmentation on unpaired bi-modal datasets. With the addition of known healthy images, an unsupervised objective encourages the model to disentangling tumors from the background, which parallels the segmentation task. Then, by teaching the model to convert images across modalities, we leverage available pixel-level annotations from the source modality to enable segmentation in the unannotated target modality. We evaluated the performance on a brain tumor segmentation dataset composed of four different contrast sequences from the public BraTS 2020 challenge data. We report consistent improvement in Dice scores over state-of-the-art domain-adaptive baselines on the unannotated target modality. Unlike the prior art, M-GenSeg also introduces the ability to train with a partially annotated source modality.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
TextBraTS: Text-Guided Volumetric Brain Tumor Segmentation with Innovative Dataset Development and Fusion Module Exploration
Autoadaptive Medical Segment Anything Model
Pre-Trained LLM is a Semantic-Aware and Generalizable Segmentation Booster
Simple is what you need for efficient and accurate medical image segmentation
SWDL: Stratum-Wise Difference Learning with Deep Laplacian Pyramid for Semi-Supervised 3D Intracranial Hemorrhage Segmentation
SRPL-SFDA: SAM-Guided Reliable Pseudo-Labels for Source-Free Domain Adaptation in Medical Image Segmentation
토론
이 논문과 연결된 포럼 글이 아직 없습니다.